Study guide

2.3 Mechanical Ventilation Modes and Settings

Board Certified Critical Care Pharmacist Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pathophysiology and Recognition of Critical Illness

1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness

2 Chapter 2: Medical Devices and Circulatory Support

2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care

3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management

3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation

4 Chapter 4: Vasoactive and Inotropic Therapy in Shock

4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock

5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)

5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness

6 Chapter 6: Cardiovascular Emergencies

6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias

7 Chapter 7: Pulmonary and Infectious Diseases in the ICU

7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU

8 Chapter 8: Neurocritical Care

8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury

9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies

9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy

10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition

10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral

11 Chapter 11: Quality, Safety, and Clinical Guidelines

11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions

12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine

12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

13 Chapter 13: Treatment Planning and Care Coordination

13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education

2.3 Mechanical Ventilation Modes and Settings

Key Takeaways Explain This Topic AI

Volume-controlled ventilation delivers a set tidal volume, resulting in variable peak airway pressures depending on lung compliance.

Pressure-controlled ventilation delivers a set pressure, leading to variable tidal volumes; it is often used in ARDS to limit barotrauma.

Positive End-Expiratory Pressure (PEEP) prevents alveolar collapse, improves oxygenation, and increases functional residual capacity.

Synchronized Intermittent Mandatory Ventilation (SIMV) allows for spontaneous breathing between mandatory breaths, helping to prevent diaphragm atrophy.

Last updated: July 2026

Mechanical ventilation provides life-saving respiratory support but carries significant risks, including ventilator-induced lung injury (VILI) and ventilator-associated pneumonia (VAP). Understanding the interplay of ventilator settings is crucial for the critical care pharmacist managing sedation, analgesia, and neuromuscular blockade.

Basic Ventilator Settings

Regardless of the specific mode, several core parameters are configured on the ventilator:

Fraction of Inspired Oxygen (FiO2): The percentage of oxygen delivered. Room air is 21%. The goal is usually an SpO2 > 88-92% or PaO2 > 60 mmHg while minimizing FiO2 (ideally < 60%) to prevent oxygen toxicity.

Positive End-Expiratory Pressure (PEEP): The pressure maintained in the lungs at the end of exhalation. Normal physiological PEEP is ~5 cm H2O. Higher PEEP levels (e.g., 10-20 cm H2O) are used to stent open collapsed alveoli (recruitment), improving oxygenation and compliance.

Respiratory Rate (RR) or Frequency: The set number of breaths delivered per minute. Controls ventilation and PaCO2 clearance.

Tidal Volume (Vt): The volume of gas delivered per breath (in volume-controlled modes). Typically dosed based on predicted body weight (PBW), not actual body weight, at 6-8 mL/kg.

Peak Inspiratory Pressure (PIP): The maximum pressure reached in the airways during inspiration.

Primary Modes of Mechanical Ventilation

Ventilator modes dictate how the machine initiates, sustains, and terminates a breath, and how it interacts with the patient's spontaneous efforts.

Assist-Control (AC) or Continuous Mandatory Ventilation (CMV)

In AC modes, the ventilator delivers a guaranteed minimum minute ventilation. The machine provides a set number of breaths, but if the patient triggers an additional breath, the ventilator delivers a full assisted breath at the set volume or pressure.

Volume Control (AC-VC): The clinician sets the Tidal Volume (Vt). The ventilator delivers this exact volume, meaning the Peak Inspiratory Pressure (PIP) will vary based on the patient's airway resistance and lung compliance.

Risk: Barotrauma if lung compliance suddenly decreases, causing pressures to spike.

Pressure Control (AC-PC): The clinician sets the Inspiratory Pressure. The ventilator delivers this exact pressure, meaning the Tidal Volume will vary.

Risk: Volutrauma or hypoventilation if lung compliance changes, resulting in tidal volumes that are too high or too low.

Synchronized Intermittent Mandatory Ventilation (SIMV)

SIMV delivers a set number of mandatory breaths synchronized with the patient's effort. However, unlike AC, if the patient takes spontaneous breaths between the mandatory breaths, the ventilator does not provide full support; the patient dictates the volume of those spontaneous breaths (though pressure support is usually added to help overcome the resistance of the endotracheal tube). SIMV is often used as a weaning mode.

Pressure Support Ventilation (PSV)

This is a spontaneous mode. The patient dictates the respiratory rate and inspiratory time. The ventilator simply provides a set positive pressure during inspiration to assist the patient's effort, increasing the tidal volume and decreasing the work of breathing. The patient must have a consistent, reliable respiratory drive to use PSV safely. It is the primary mode used for Spontaneous Breathing Trials (SBTs).

Pressure Regulated Volume Control (PRVC)

PRVC is a dual-control mode. The clinician sets a target Tidal Volume. The ventilator delivers pressure-controlled breaths, continuously adjusting the inspiratory pressure breath-by-breath to achieve the target volume while using the lowest possible pressure. It offers the safety of volume control with the comfort and flow dynamics of pressure control.

The ARDSNet Protocol: Lung-Protective Ventilation

Acute Respiratory Distress Syndrome (ARDS) is characterized by severe inflammation, pulmonary edema, and collapsed alveoli. Traditional ventilation strategies often worsened ARDS by causing overdistension of the healthy alveoli.

The landmark ARDSNet trial established the standard of care for "lung-protective ventilation":

Low Tidal Volumes: 4-6 mL/kg of predicted body weight (PBW). This prevents overstretching and barotrauma/volutrauma.

Plateau Pressure Goal: Keep plateau pressure (the pressure in the alveoli at the end of inspiration) < 30 cm H2O.

Permissive Hypercapnia: Because tidal volumes are low, PaCO2 often rises. This respiratory acidosis is tolerated (usually maintaining pH > 7.20-7.25) to protect the lungs.

High PEEP: Used to recruit and maintain open alveoli, guided by standardized PEEP/FiO2 tables.

Liberation from Mechanical Ventilation

Weaning involves assessing the patient's readiness to breathe independently. This is typically evaluated via a Spontaneous Breathing Trial (SBT), where the patient is placed on minimal support (e.g., PSV of 5/5 cm H2O) for 30-120 minutes.

Rapid Shallow Breathing Index (RSBI)

The RSBI is a classic predictor of successful extubation.

Formula: RSBI = Respiratory Rate (breaths/min) / Tidal Volume (Liters)

Interpretation: An RSBI < 105 suggests a high likelihood of successful extubation. Rapid, shallow breathing (high rate, low volume) yields a high RSBI, indicating respiratory muscle fatigue and likely failure.